Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia

Launched by TANTA UNIVERSITY · Feb 25, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different devices, the I-gel and Ambu AuraGain, used to help children breathe during orthopedic surgeries while they are under general anesthesia. The study aims to see how much air can be safely put into the stomach using each device and how this affects the pressure in the throat area and any complications that might happen after surgery.

To be part of this trial, children must be between 2 and 12 years old and scheduled for specific types of orthopedic surgeries. They also need to be in good health, classified as ASA physical status I or II, which means they have no serious medical issues. However, children with certain conditions, like reflux problems or a history of breathing issues, cannot participate. If your child qualifies and chooses to join, they will receive one of the two devices during their surgery, and the doctors will monitor their recovery closely. This study aims to improve care and safety for young patients undergoing surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged from 2 to 12 years.
• • Both sexes.
• • American Society of Anesthesiologists (ASA) physical status I and II.
• • Scheduled for elective orthopedic operations in a supine position under general anesthesia.
• Exclusion Criteria:
• • Patients with a known history of gastro-oesophageal reflux disorders.
• • Full Stomach.
• • Anticipated difficult mask ventilation or intubation.
• • Body mass index "BMI" exceeding 20% of the ideal.
• • A history of chest problems.
• • History of the gastrointestinal tract or thoracic surgeries.